US HB3446 | 2019-2020 | 116th Congress

Status

Spectrum: Moderate Partisan Bill (Democrat 40-7)
Status: Introduced on June 24 2019 - 25% progression, died in committee
Action: 2019-06-25 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

National Commission on Scleroderma and Fibrotic Diseases Act of 2019

Sponsors


History

DateChamberAction
2019-06-25HouseReferred to the Subcommittee on Health.
2019-06-24HouseReferred to the House Committee on Energy and Commerce.
2019-06-24HouseIntroduced in House

Same As/Similar To

SB2477 (Related) 2019-09-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback